Mycobiome

The mycobiome is the collective fungal community that inhabits various sites of a host organism, such as the gut, skin, and respiratory tract. In humans, fungal populations are a minor but essential component of the microbiome, influencing metabolic functions, immunity, microbial community structure, and susceptibility to disease. The composition of the mycobiome varies by body site and individual and may be altered by environmental factors and diet. Shifts or dysregulation in the mycobiome have been linked to conditions including hepatitis, cystic fibrosis, obesity, inflammatory bowel disease, and cancer. Although not a therapeutic target or receptor, the mycobiome is significant in health and disease via its complex roles in ecological balance within the host. Key clarifications: - Mycobiome is not a molecule or receptor; it is a term defining a group/community of fungi. - It cannot be directly targeted by drugs as a discrete molecular entity but can be indirectly affected by antifungal agents and interventions that alter fungal populations. - Research into disease associations, cancer biomarkers, and microbiome modulation may make the mycobiome relevant in diagnostics and therapeutics, though not as a classic molecular target.

Other names

Fungal microbiomeMycobiota